HomeR3X1 • FRA
add
Opus Genetics Inc
Previous close
€0.85
Day range
€0.85 - €0.85
Year range
€0.75 - €2.12
Market cap
29.38M USD
Avg Volume
477.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.87M | -67.60% |
Operating expense | 3.13M | 35.97% |
Net income | -7.53M | -235.34% |
Net profit margin | -194.62 | -517.73% |
Earnings per share | -0.29 | -216.00% |
EBITDA | -8.01M | -225.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.64M | -13.52% |
Total assets | 40.39M | -25.47% |
Total liabilities | 6.09M | 55.77% |
Total equity | 34.30M | — |
Shares outstanding | 31.57M | — |
Price to book | 0.65 | — |
Return on assets | -46.99% | — |
Return on capital | -53.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.53M | -235.34% |
Cash from operations | -5.13M | -70.83% |
Cash from investing | — | — |
Cash from financing | 353.00K | -93.43% |
Net change in cash | -4.78M | -301.31% |
Free cash flow | -2.67M | 52.71% |
About
Founded
2018
Website
Employees
14
